Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 NAFLD fibrosis score: is it ready for wider use in clinical practice and for clinical trials?

Literature DB >> 23973850

NAFLD fibrosis score: is it ready for wider use in clinical practice and for clinical trials?

Samer Gawrieh¹, Naga Chalasani.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2013 PMID： 23973850 PMCID： PMC4139920 DOI： 10.1053/j.gastro.2013.08.025

Source DB: PubMed Journal: Gastroenterology ISSN： 0016-5085 Impact factor: 22.682

× No keyword cloud information.

16 in total

Review 1. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

Authors: Giovanni Targher; Christopher P Day; Enzo Bonora
Journal: N Engl J Med Date: 2010-09-30 Impact factor: 91.245

2. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.

Authors: Richard K Sterling; Eduardo Lissen; Nathan Clumeck; Ricard Sola; Mendes Cassia Correa; Julio Montaner; Mark S Sulkowski; Francesca J Torriani; Doug T Dieterich; David L Thomas; Diethelm Messinger; Mark Nelson
Journal: Hepatology Date: 2006-06 Impact factor: 17.425

3. Long-term follow-up of patients with nonalcoholic fatty liver.

Authors: Nila Rafiq; Chunhong Bai; Yun Fang; Manirath Srishord; Arthur McCullough; Terry Gramlich; Zobair M Younossi
Journal: Clin Gastroenterol Hepatol Date: 2008-11-07 Impact factor: 11.382

4. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

Authors: Chun-Tao Wai; Joel K Greenson; Robert J Fontana; John D Kalbfleisch; Jorge A Marrero; Hari S Conjeevaram; Anna S-F Lok
Journal: Hepatology Date: 2003-08 Impact factor: 17.425

5. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease.

Authors: Paul Angulo; Elisabetta Bugianesi; Einar S Bjornsson; Phunchai Charatcharoenwitthaya; Peter R Mills; Francisco Barrera; Svanhildur Haflidadottir; Christopher P Day; Jacob George
Journal: Gastroenterology Date: 2013-07-13 Impact factor: 22.682

6. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.

Authors: Janus P Ong; Angela Pitts; Zobair M Younossi
Journal: J Hepatol Date: 2008-07-09 Impact factor: 25.083

7. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.

Authors: Paul Angulo; Jason M Hui; Giulio Marchesini; Ellisabetta Bugianesi; Jacob George; Geoffrey C Farrell; Felicity Enders; Sushma Saksena; Alastair D Burt; John P Bida; Keith Lindor; Schuyler O Sanderson; Marco Lenzi; Leon A Adams; James Kench; Terry M Therneau; Christopher P Day
Journal: Hepatology Date: 2007-04 Impact factor: 17.425

8. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

Authors: S A Harrison; D Oliver; H L Arnold; S Gogia; B A Neuschwander-Tetri
Journal: Gut Date: 2008-04-04 Impact factor: 23.059

NAFLD fibrosis score: is it ready for wider use in clinical practice and for clinical trials?

Review 1. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

2. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.

3. Long-term follow-up of patients with nonalcoholic fatty liver.

4. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

5. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease.

6. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.

7. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.

8. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

Review 9. Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal.

10. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.

1. Portal Venous Pulsatility Index: A Novel Biomarker for Diagnosis of High-Risk Nonalcoholic Fatty Liver Disease.

Review 2. MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis.

3. Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation, and Death in NAFLD.